Has the incidence of total joint arthroplasty in rheumatoid arthritis decreased in the era of biologics use? A population-based cohort study
- 9 August 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 61 (5) , 1819-1830
Abstract
To determine whether the introduction of biological DMARDs (bDMARDs) was associated with reduced incidences of total hip and knee arthroplasty (THA/TKA) among patients with RA compared with OA. Using a population-based cohort in British Columbia, Canada, RA and OA patients diagnosed between 1995 and 2007 were divided into semi-annual cohorts according to diagnosis date. For each cohort, we calculated 8-year incidence rates of THA and TKA. We compared levels and trends of THA/TKA incidence in RA/OA patients diagnosed during pre-bDMARDs (1995–2001) and post-bDMARDs (2003–2007) periods using interrupted time-series analysis, adjusting for baseline characteristics. Adjusted 8-year total joint arthroplasty incidence estimated for RA/OA cohorts diagnosed five years after bDMARDs introduction were compared with expected rates assuming no bDMARDs introduction, based on extrapolation of pre-bDMARDs trends. We identified 60 227 RA and 288 260 OA incident cases. For cohorts diagnosed pre-bDMARDs, 8-year THA/TKA incidence rates increased over time in both RA and OA. For cohorts diagnosed post-bDMARDs, these rates decreased over time in RA but continued to increase for OA. For RA, differences between the post- and pre-bDMARDs secular trends in incidence rates were −0.49 (P = 0.002) for THA and −0.36 (P = 0.003) for TKA, compared with +0.40 (P = 0.006) and +0.54 (P < 0.001), respectively, for OA. For RA cohorts diagnosed five years after bDMARDs introduction, 8-year incidences were 26.9% and 12.6% lower for THA and TKA, respectively, than expected rates. In contrast, corresponding rates in OA were higher by 11.7% and 16.6%, respectively. Arthritis onset after bDMARDs introduction is associated with a significant reduction in THA/TKA incidence in RA, but not in OA. The reduction reflects a significant improvement in RA treatment during the biological era.Keywords
Funding Information
- Canadian Institute of Health Research (THC-135235, MOP-130480)
- Natural Sciences and Engineering Research Council (2018–04313)
This publication has 34 references indexed in Scilit:
- The decline in joint replacement surgery in rheumatoid arthritis is associated with a concomitant increase in the intensity of anti-rheumatic therapyActa Orthopaedica, 2013
- Tumour necrosis factor blockade for the treatment of erosive osteoarthritis of the interphalangeal finger joints: a double blind, randomised trial on structure modificationAnnals of the Rheumatic Diseases, 2012
- Orthopedic Surgery Among Patients with Rheumatoid Arthritis 1980–2007: A Population-based Study Focused on Surgery Rates, Sex, and MortalityThe Journal of Rheumatology, 2012
- Decrease in the incidence of total hip arthroplasties in patients with rheumatoid arthritis - results from a well defined population in south SwedenArthritis Research & Therapy, 2011
- Changes in the rates of joint surgery among patients with rheumatoid arthritis in California, 1983–2007Annals of the Rheumatic Diseases, 2010
- 342 VALIDATION OF OSTEOARTHRITIS DIAGNOSIS IN ADMINISTRATIVE DATA USING A CLINICALLY AND RADIOLOGICALLY DEFINED POPULATION-BASED COHORT OF OSTEOARTHRITISOsteoarthritis and Cartilage, 2008
- Comparison and Validity of Procedures Coded With ICD-9-CM and ICD-10-CA/CCIMedical Care, 2008
- Further evidence concerning the use of a clinical comorbidity index with ICD-9-CM administrative dataJournal of Clinical Epidemiology, 1993
- Presentation adapting a clinical comorbidity index for use with ICD-9-CM administrative data: Differing perspectivesJournal of Clinical Epidemiology, 1993
- A Simple, Positive Semi-Definite, Heteroskedasticity and Autocorrelation Consistent Covariance MatrixEconometrica, 1987